Fellowship & Membership

  • FSCAI
  • FESC
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Field of Expertise

  • Coronary Interventions
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran

    Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Fellowship & Membership

  • FSCAI
  • FESC
  • Field of Expertise

  • Coronary Interventions
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran

    Field of Expertise

  • Coronary Interventions
  • Fellowship & Membership

  • FSCAI
  • FESC
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran

    Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Fellowship & Membership

  • FSCAI
  • FESC
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Field of Expertise

  • Coronary Interventions
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran

    Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Fellowship & Membership

  • FSCAI
  • FESC
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Field of Expertise

  • Coronary Interventions
Appointment
Health Check
Contact Us
Write to COO
Call Us